New biomarkers may sharpen cancer diagnosis in bile duct blockages
NCT ID NCT02531607
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether measuring certain substances in bile and blood can more accurately diagnose cancer in people with bile duct blockages. Researchers will compare these new tests with standard methods in 500 adults undergoing a procedure called ERCP. The goal is to find better ways to tell cancerous from non-cancerous blockages.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMPULLARY CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AdventHealth
Orlando, Florida, 32803, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Which bile duct stone removal method is safer? a large swedish study investigates
- Blood and gut clues may flag pancreatic cancer risk early
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?